Offer - Urjas Oil for just ₹ 1
StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet safe for pregnant women?
StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet safe during breastfeeding?
Side effects of StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet on breastfeeding women are very mild.
What is the effect of StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet on the Kidneys?
StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet may have mild side effects on the kidneys.
What is the effect of StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet on the Liver?
StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet has very mild side effects on the liver.
What is the effect of StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet on the Heart?
StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet unless your doctor advises you to do so -
Is this StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet habit forming or addictive?
StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet is not addictive in nature.
Interaction between Food and StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet
Taking StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet with food does not cause any problems.
Interaction between Alcohol and StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet
Taking StayHappi Sodium Valproate 135 Mg + Valproic Acid 58 Mg Controlled Release Tablet with alcohol can have severely harmful effects on your health.
No. StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet Should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine own your own can cause unintended side effects.
Yes, StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet is safe to use, if taken in the prescribed amount for a specified time as advised by the doctor. However, few side effects are observed at the therapeutic doses such as drowsiness, dizziness, tremor, slurred speech, and confusion. Do not hesitate to inform your doctor if you are facing any of the above.
Yes, StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet can cause sleepiness and drowsiness. It is a common side effect of antiepileptic medicine. If you observe these unpleasant effects after consuming medicine, please consult your doctor and follow his/her instructions.
No, you can not take StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet with tramadol, harmful interaction have been reported between them. Tramadol may decrease the seizure threshold in some patient and also decrease the anticonvulsant activity of StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet. Thus use StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet with tramadol is not recommended, until unless it is prescribed by your doctor.
StayHappi Sodium Valproate + Valproic Acid Controlled Release Tablet is a brand name for sodium valproate. It is a prescription drug that belongs to the class of medicine called anti-epileptic drug, also known as an anticonvulsant and anti-seizure medication. It is used in the treatment of epilepsy (seizure). It is also used to treat mania associated bipolar disorder and prevent the episodes of a migraine headache. The injectable form of this drug is used to treat complex partial seizures, simple and complex absence seizures.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
